COD GALBEN: 27-09-2021 Intre 07:00 si 09:00 se va semnala ceață care determină reducerea vizibilității local sub 200 m și izolat sub 50 m in Județul Sălaj, Județul Cluj, Județul Bistriţa-Năsăud; COD GALBEN: 27-09-2021 Intre 06:25 si 09:00 se va semnala ceață care determină reducerea vizibilității local sub 200 m și izolat sub 50 m in Județul Cluj; COD GALBEN: 27-09-2021 Intre 06:15 si 09:00 se va semnala local ceață care determină reducerea vizibilității local sub 200 m și izolat sub 50 m in Județul Covasna, Județul Braşov, Județul Braşov, Județul Sibiu; COD GALBEN: 27-09-2021 Intre 05:00 si 09:00 se va semnala ceață care determină reducerea vizibilității local sub 200 m și izolat sub 50 m in Județul Harghita;
Modifică dimensiunea fontului:
A number of 208,800 doses of the Vaxzevria (AstraZeneca) vaccine will arrive on Tuesday at the "Cantacuzino" National Institute for Medical-Military Research and Development, informs the National Coordinating Committee on COVID-19 Vaccination Activities (CNCAV).
According to the quoted source, transport is provided by the manufacturing company, and the vaccine doses will be brought to Bucharest by land.
"The doses will be stored at the National Storage Centre, and in the next period they will be distributed to the existing regional centres nationwide. The National Storage Centre for vaccines against COVID-19 within the "Cantacuzino" Institute is fully authorised and approved by the National Agency for Medicines and Medical Devices of Romania (ANMDMR), the national authority that has competence in the field of medicine for human use," states the same source.
To date, Romania has received 3,165,200 doses of the vaccine produced by the AstraZeneca pharmaceutical company, and since February 15, 835,780 doses have already been used to immunise the population. AGERPRES (RO - author: Roberto Stan, editor: Mihai Simionescu; EN - editor: Adina Panaitescu)
The content of the www.agerpres.ro website has the exclusive purpose of public informing.
All the information published on this website by AGERPRES is protected by relevant legal dispositions.
It is forbidden to copy, reproduce, recompile, decompile, distribute, publish, display, modify, create derived components or products or full services, as well as any exploitation of the site's content.
The use of the Comments section entails your obligation to respect the AGERPRES terms and conditions in regards to the publishing of comments on the www.agerpres.ro.